Literature DB >> 7011284

Steroid-responsive bilateral sensorineural hearing loss and immune complexes.

J Kanzaki, T Ouchi.   

Abstract

We have recognized in recent years that some cases with idiopathic bilateral sensorineural hearing loss which showed acute progression in either ear responded to steroid and that the improved hearing level could be maintained by longterm administration of steroid only. Forty cases of bilateral sensorineural hearing loss were selected for study. In most of these cases hearing deterioration of either ear was confirmed by audiometry. Eight of fifteen cases with marked improvement have been proved to respond to steroid treatment. These eight cases include three cases with syphilitic deafness and one case with aortitis syndrome. In four other cases the causes are still unknown, but could be due to autoimmune mechanisms. In four of 25 cases the immune complexes (IC) value was higher than normal and three among them responded to steroid. Since a high IC value has been reported in lupus nephritis, immunologic examinations are necessary for patients over 30 years of age with bilateral sensorineural hearing loss.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011284     DOI: 10.1007/bf00665374

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  2 in total

1.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

  2 in total
  13 in total

1.  Inhibition of the activation and recruitment of microglia-like cells protects against neomycin-induced ototoxicity.

Authors:  Shan Sun; Huiqian Yu; Hui Yu; Mei Honglin; Wenli Ni; Yanping Zhang; Luo Guo; Yingzi He; Zhen Xue; Yusu Ni; Jin Li; Yi Feng; Yan Chen; Ruijin Shao; Renjie Chai; Huawei Li
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

2.  NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Kelly Sheehan; Tejbeer Kaur; Sandeep Sheth; Jennifer Bunch; Christopher Perro; Leonard P Rybak; Vickram Ramkumar
Journal:  Antioxid Redox Signal       Date:  2010-12-07       Impact factor: 8.401

3.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27

4.  Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation.

Authors:  Hitoshi Satoh; Gary S Firestein; Peter B Billings; Jeffrey P Harris; Elizabeth M Keithley
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

5.  Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.

Authors:  Hongseob So; HyungJin Kim; Jeong-Han Lee; Channy Park; Yunha Kim; Eunsook Kim; Jin-Kyung Kim; Ki-Jung Yun; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; David J Lim; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2007-05-22

6.  Antigen non-specific immunological tests in progressive sensorineural hearing loss.

Authors:  M Savastano; C Raffael; G De Franchis; C Andreoli
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  Toxicology study for magnetic injection of prednisolone into the rat cochlea.

Authors:  M Shimoji; B Ramaswamy; M I Shukoor; P Benhal; A Broda; S Kulkarni; P Malik; B McCaffrey; J-F Lafond; A Nacev; I N Weinberg; B Shapiro; D A Depireux
Journal:  Eur J Pharm Sci       Date:  2018-06-19       Impact factor: 4.384

8.  Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.

Authors:  T Kaur; D Mukherjea; K Sheehan; S Jajoo; L P Rybak; V Ramkumar
Journal:  Cell Death Dis       Date:  2011-07-21       Impact factor: 8.469

Review 9.  Biological and clinical aspects of autoimmune inner ear disease.

Authors:  A J Griffith
Journal:  Yale J Biol Med       Date:  1992 Jan-Feb

10.  Immune complex-associated deafness: preliminary communication.

Authors:  G B Brookes
Journal:  J R Soc Med       Date:  1985-01       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.